Clinical trial
The Immediate Extent of the Hypoalgesic Effect Following Central Mobilisations to L3, L4 and L5
NCT06548633 is registered in ClinicalTrials.gov with Darren Cooper as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Immediate Extent of the Hypoalgesic Effect Following Central Mobilisations to L3, L4 and L5
- Lead sponsor
- Darren Cooper
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 4, 2018
- Completion date
- May 28, 2019
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.